chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My son has had loose stools and intermittent diarrhea with occasional regular stools. This began around 1/10/2023.  He doesn't seem to have pain, because he says his tummy doesn't hurt. We have tried isolating foods from his diet, such as milk and fruit, as was recommended by his pediatrician. On 2/24/2023, we took him to his physician, who suggested that we continue isolating certain foods. She said his symptoms were likely caused by a food allergy. She asked us if we had had any tummy bugs in the family at any point, and we confirmed that we had, though my son is the only one with an ongoing problem. She also suggested skin and blood tests for allergies for my son. My son has not yet undergone any tests, though. Since we have begun isolating foods, my son's symptoms have improved. The symptoms are still present, though less frequent.
Vaccine expired July 2023, I administered the vaccine on 8/01/23. I forgot today's date, resulting in the error. No adverse reactions known at this time.
80 yof with HTN, HLD, DM2, CKD3, Alzheimer dementia, CAD ( PCI in 2002), s/p fall in 4/2021 resulting in subdural hematoma and T8 vertebral fx requiring hospitalization 4/20-5/2/2021, who was transferred from her SNF residence with shortness of breath and hypoxia and was found to have COVID-19 PNA.   CORONAVIRUS COVID-19 PNEUMONIA (10/25/2021)  ACUTE HYPOXEMIC RESPIRATORY FAILURE (10/25/2021) Mildly elevated Troponin.   Assessment:  Pt has completed 2 doses of COVID vaccine. Initially required 2lit of supplemental O2 to keep sat>90. She was started on Remdesivir and 3 doses of decadron and with improving oxygenation medications were discontinued.  She has been able to transition to room air  At rest and work with PT with no supplemental O2 needs.  Mildly elevated D dimer is likely secondary  to COVID infection. And she had Mildly elevated troponin (0.07-0.1-0.06)  likely due to demand ischemia from COVID pneumonia.  Incentive spirometry encouraged.  IMPROVE VTE SCORE   D-dimer > 2x Upper Limit of Normal - 2 POINTS Immobilization for at least 7 days - 1 POINTS Age more than 60 years. - 1 POINTS    She was not on chemical DVT prophylaxis while in house given hx of prior SDH hx and noted down trending WBC and PLT counts. As the counts seems steady to improved, I discussed the case with neurology on call, given no symptoms and absence of blood in last CT head in 4/202, it would be ok to treat with chemical DVT prophylaxis. I will also request for a repeat CBC in a week.     HTN / CAD s/p stents She was initially started on half dose of her BP meds and as BP started to increase, PTA dose of BP meds were resumed, however metoprolol was kept at half dose with noted resting HR of 50's-60's on current dose.  - continue PTA lasix 10 mg daily    DM 2.  Hba1c 7.6 4/2021. Fasting glucose was 200s. Pt was on NPH 40 mg qam and 10 mg qpm at SNF+ glipizide per PTA meds.  Glipizide was on hold in the hospital and While on decadron pm dose of NPH was increased in house, however with discontinuation of decadron and 50-60% of meal intake, I am holding off glipizide upon discharge.    Thrombocytopenia sec to COVID pneumonia: platelet 130's also is leukopenic ?COVID related. Levels better today.  Will arrange for follow up CBC in a week.     1/2 positive blood cx with GPC in clusters from admission with no fever and overall improvement and coag negative staph growth suspect contaminant.  Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Hypoxic respiratory failure, COVID-19 disease
The afternoon after getting the vaccine, my lips started tingling and the next morning they were swollen. They were visably swollen for most of a day but after that, they still continued to feel like something is inside of them. In addition to that, I just felt sick for a day and everything tasted like metal. The swelling is what concers me about getting the 2nd dose of the vaccine.
MATERNAL EXPOSURE DURING PREGNANCY; This spontaneous pregnancy report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included: covid infection, and other pre-existing medical conditions included: The patient had Para 1 and gravida 1. The outcome of birth was livebirth. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, expiry: UNKNOWN) dose was not reported, administered on AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On AUG-2021, the patient experienced maternal exposure during pregnancy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from maternal exposure during pregnancy. This report was non-serious. This parent/child case is linked to 20220440088.
On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced RASH MACULAR (little spot on forehead), RASH (rash on face and chest), ARTHRALGIA (achy joints) and PYREXIA (low grade fever 98.8). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN BAYER) at an unspecified dose and frequency. At the time of the report, RASH MACULAR (little spot on forehead), RASH (rash on face and chest), ARTHRALGIA (achy joints) and PYREXIA (low grade fever 98.8) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Heart rate: 86 (normal) pulse of 86.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. Concomitant medications were not provided
SVT- two separate runs. 10/12/21 for approx 30 mins and 10/22/21 for approx 20 mins. Syncopal episode 10/22/21. Heart palpitations- off and on since 10/12/21 Tachycardia/ bradycardia arrhythmias, which include rapid heart rate changes upon changing positions- current since 10/12/21 Joint inflammation  Redness/ blotchy was on face Was hospitalized, fluid resuscitated to rule out dehydration,  and have  received a holter monitor. Will be having an echocardiogram as well as possible other tests and have not ruled out POTS.
fever to 104.5 documented in 1st 24 hrs p/vax; fever poss higher;
About 11:15am, the day after the shot which was 5/12/21, I began having chills. Then developed a temperature and headache. I slept off and on through afternoon. By 6 pm, my temperature and chills were gone. Still have a lingering headache through 5/13/21 thus far. In the name of science and data collection, I felt it was good to share my experience.
1. In early April, my vision impaired suddenly (need to wear glasses to watch TV. I didn't need to wear glasses to watch TV  before 1st shot. ) 2. Began to have substantial hair loss for 2-3 months since April. 3. All joints in my left hand was in pain for two days. Then the pain  went away. 4. My injection spot was in pain for a few days. then it went away.
Patient states received Hepatitis B vaccine on 07/21/2005 here.  Complaint of headache, shortness of breath, drwosiness, 1 hour after receiving vaccine.  Stated increased temperature.  Saw private doctor for symptoms on 07/22/2005 - temperature 99 degrees.  Advised continue pain reliever.
Chills, severe body aches, 103 degree fever over 12 hours, symptoms gradually diminishing over next 12.
getting VN; getting VN; Really messing with my like and equilibrium.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), VOMITING (non-serious), outcome "unknown" and all described as "getting VN"; BALANCE DISORDER (non-serious), outcome "unknown", described as "Really messing with my like and equilibrium.".  Additional information: This is the second time I am getting VN after receiving the COVID vaccine. It happens within 2 days of the shot.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300180436 same patient, event and product/different dose;
2MAY97 approx 115PM during evening pt started having fevers this cont;5MAY97 pt taken to clinic;pt sent home w/cough syrup & APAP;4PM 6MAY97 pt temp cont;pt still coughing;t104;adm to hosp w/viral pneumonia;croup tent used;
The following  day after the 1st dose vaccine, I went to a routine doctor's visit, a swollen lymph node was detected on the right side of my neck.  I was instructed to keep an eye on it and to get an ultrasound if not improved.  On 3/29/2021, I went ahead to get my 2nd dose Moderna vaccine (lot 020B21A IM LA).  On 6/9/2021, I went back to the doctor to check on my lymph nodes and it was still there so I scheduled an ultrasound.  My ultrasound is scheduled for tomorrow 7/7/2021.
side effects were "worse" with the second shot; headache; fever; shakes; feeling cold; hey woke up in bed and were hot and took all the layers off; This case has been considered invalid as Unspecified AE. Upon follow up 4 (13Jan2022) information, this case become valid as events were added.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). An adult female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Potentially anxiety" (unspecified if ongoing); "loose bone in foot/leg" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Allergies: lavender, reaction(s): "Allergies". Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 immunization.  The following information was reported: CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "side effects were "worse" with the second shot"; HEADACHE (non-serious), outcome "unknown", described as "headache"; PYREXIA (non-serious), outcome "unknown", described as "fever"; TREMOR (non-serious), outcome "unknown", described as "shakes"; FEELING COLD (non-serious), outcome "unknown", described as "feeling cold"; FEELING HOT (non-serious), outcome "unknown", described as "hey woke up in bed and were hot and took all the layers off".  Additional Information:Started with a headache for a couple of hours (maybe 2) and then it turned into a fever with shakes that caused them to layer up due to feeling cold. They said they woke up in bed and were hot and took all the layers off, and they implied that was when the effects broke.They said side effects were "worse" with the second shot.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mild soreness at site of injection, Mild headache, tired and weakness, mild chills, nose bleed in the morning which is not normal.
pt recv vax 9SEP96 & mom called 10SEP96 to report pt had inc temp of 103-104 since 9SEP96 PM, not relieved w/APAP;pt was referred to PCP, note made on vax card;
2MAR got big blotches & ankles swollen;4MAR to emergency told to stop using lotion & blotches & swelling would go away;6MAR sz x 2hr each last a few sec;7MAR hosp ER-sz, fever 105 MD stated rxn to MMR told to give APAP & DPH
Deltoid area of left arm swollen, red, hot to touch. Patient ran 102 fever for approximately 12 hours, felt nauseous. Immunizing pharmacist recommended patient take acetaminophen q6 hours. Protocol physician and patient's primary care physician contacted and patient advised to alternate ibuprofen and acetaminophen orally and alternate hot and cold compresses to affected area of arm.
Soon as we left pharmacy we left to eat, my son started making weird noises and couldn't see or hear and ears were ringing. I sat next to him and felt an increase amount of body heat, ringing in ears, vision loss, pressure at nose that moved up to center of forehead.  It lasted 5 minutes and started to subside and he was fine after that. I put water on back of neck to get body temp down, and I dont know that he had a fever but I could feel the body heat.
Adverse reaction- Pleurisy ...went to hospital with heart attack like symptoms pain in left side of chest and arm (vaccine in left arm) several test - blood work, ekg and x-rays...given 800 mg ibuprofen for pain and swelling
Acute cellulitis (L) arm below injection site w/ in 4 hrs of injection. Hospitalized 24 hrs later for 3 days. Treatment included IV antibiotics, prednisone, bloodwork, breathing treatments, abdominal CT. Run of tachycardia, monitoring, follow up visits.
1/2 after vaccine (MMR) vomiting, lethargic, abdominal pain- Administered Solucortef 1 cc for CAH and Childrens Benadryl 1 1/2 tsp.
faint/syncopal episode; faint and flushed; This spontaneous report as received from a finance an business economic reported an  adverse event reported to him by medical assistant at health care professional office refers to a 16-year-old male patient. There was no information about the patient's medical history, concurrent conditions or concomitant medication. Approximately on 26-AUG-2020, reported as 6 months ago, the patient was vaccinated with a dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), intramuscular for prophylaxis (dose, lot number and expiration date were not reported).   Approximately on 26-AUG-2020, reported as 6 months ago, the patient became "faint and flushed", after adminsitration of the vaccine. The patient was leaned back on table and symptoms resolved, approximately on the same date, on 26-AUG-2020 . The causal relationship between the events and therapy with  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) were not reported.  Upon internal review the events faint was considered to be medically significant.
Eyes starting swelling and watering.  Then facial swelling.  No Shortness of breath.
PATIENT BEGAN FEELING VERY DIZZY ABOUT 10 MINUTES AFTER RECEIVING VACCINE. SHE THEN STATED SHE COULD NOT SEE. WAS ALERT AND TALKING, JUST FEELING VERY DIZZY AND UNABLE TO SEE. CALLED EMS, GAVE WATER, NO OTHER TREATMENT GIVEN. BEGAN FEELING BETTER AND COULD SEE WITHIN 10 MINUTES OF CALLING EMS. EMS ARRIVED, ASSESSED PATIENT. PATIENT DID NOT GO TO EMERGENCY ROOM
Patient reported pain on injection and then called to report that she had three days of reduced range of movement in the arm and a swollen right hand. Patient reports that both hand and arm have returned to normal.
swelling at the injection site; Rash; burning at injection site; This is a spontaneous report received from non-contactable reporter(s) (Other HCP) from a sales representative.  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: FX6073) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "swelling at the injection site"; RASH (non-serious), outcome "unknown"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "burning at injection site". Additional information included: there are three patients were given Prevnar 20 from the same lot number FX6073 and all three patients had the same adverse events. Rash, burning at injection site, and swelling at the injection site. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-202201170676 same drug and AE, different patient; PFIZER INC-PV202200066036 same drug and AE, different patient;
The patient was under the age of 18 when given the vaccination. The COVID19 vaccine is only approved for 18 years or older.
Right thigh swollen, was red before visit. On Omnicef already for ear infection.
No additional AEs; temperature excursion on GARDASIL 9/ temperature above 47F; This spontaneous report as received from a medical assistance, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 02-NOV-2020 (reported as today), the patient was vaccinated with an improperly storage dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # 1637648 with expiration date 19-JUN-2022 (dose, frequency, route and anatomical location were not provided) for prophylaxis. No additional adverse events reported.  The vaccine was stored at a temperature of above 47 Fahrenheit degrees, time frame of 1 hour and with not previous temperature excursion. Digital Data logger was not involved. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1637648; expirationdate: 19-JUN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Case previously recorded as MA2009-4071. Initial case report received from a physician on 09 NOV 2009. A 3-year-old male patient was accidentally vaccinated with FLUVIRIN (batch no. 10127601) i.m. on 06 NOV 2009. No adverse effect was reported. Reference no: NA09-007849.
Information has been received from a physician concerning a female who in August 2008, was vaccinated with the first dose of GARDASIL, (lot # not reported).  The patient experienced swollen tongue and itching in 24 hours after vaccination.  The staff member at the office told the patient to go to the hospital.  The office was unsure whether or not the patient did end up going and had not heard anything since.  Additional information has been requested.
Patient received the vaccine at approximately 1500.  At 1620, she returned to report a large area of redness and warmth at the site of the injection.
Patient was anxious about shot but decided to go ahead and get it anyways. About 15 to 20 minutes after receiving the vaccine the patient returned to the pharmacy and asked that I call her an ambulance because she felt "weird". She couldn't really explain it but she said her throat felt funny and and tighter on both sides. She denied having problems breathing and had no skin reactions indicative of an allergic reaction. She said she felt clammy and just felt off. Though the patient had no reported allergies and has never had an anaphylactic reaction she had an Epipen in her purse that she said was her son's that she pulled out at one point while we were waiting on the ambulance as she said she didn't want to die at the grocery store. I did talk the patient out of using the epipen on herself prior to the EMT arrival. Upon the firefighters responding, she was found to be breathing fine and had no other symptoms that indicated she was having an allergic reaction. Her blood pressure was elevated and she was diaphoretic. The patient continued to complain that her throat felt weird as we sat with the EMT's for 30 minutes, however she decided to not go to the hospital and instead go home with her husband, take some benadryl, and have him monitor her.
RT. ARM RED, SWOLLEN AND WARM. TENDER TO TOUCH. TEMP-98.5. PT STATED SWELLING TO SIZE OF SOFTBALL. SEEN AT URGENT CARE, TREATED FOR REACTION TO VACCINE-COLD COMPRESSS/ BENADRYL 1TSP
Patient got HPV shot at 10am, at 10:05am patient got very pale and said he did not feel well. We laid him down on the table and he passed out right after. He came back around after a minute.
At 6pm and beyond had 101 fever, chills, body aches and pains, swelling of the arm the shot was in. As of today, fever down to 99, very tired and still body aches.
This case was reported in a literature article and described the occurrence of cardiac arrhythmia in a 13-year-old male subject who was vaccinated with DTPa (with small D + P), (manufacturer unspecified). On an unspecified date, the subject received an unspecified dose of DTPa (with small D + P) (administration site and route unknown, batch number not provided). 14 days after vaccination with DTPa, the subject died from cardiac arrhythmia. An autopsy was performed and showed cardiac arrhythmia. This is one of the 11 cases created from the same literature article. Summary of the literature article: Pre-licensure clinical trials for two licensed Tdap vaccines did not reveal any major safety concerns. However, routine use in large adolescent and adult populations could reveal rare and potentially serious adverse events (AEs). To characterize reported AEs following Tdap vaccination and identify potential safety concerns warranting further evaluation, we analyzed data from the Vaccine Adverse Event Reporting System (VAERS) and assessed the frequency and proportions of AEs and reporting rates (reports per 100,000 vaccine doses distributed). A total of 2090 reports (7% were serious; 55% listed Tdap alone) involving Tdap vaccines were submitted to VAERS May 2005 - June 2007. The crude reporting rate was 10.2 per 100,000 vaccine doses distributed. The median age of vaccinees was 22 years, and the female to male ratio was about 2 to 1. The majority of reports described common local and systemic signs and symptoms, such as injection site reactions, fever, and headache. Rarely reported AEs included myopericarditis, demyelinating diseases of the central nervous system, Guillain-Barre Syndrome, syncope, encephalopathy/encephalitis, seizure, Bell's palsy, anaphylaxis, and thrombocytopenia. The author's conclusion stated that because adolescents and adults were not routinely vaccinated against pertussis in the past, this surveillance summary provides important - and reassuring - information about the use of Tdap in these age groups. Although subject to the limitations of passive surveillance, the findings of this VAERS review support the pre-licensure clinical trial data with regard to the safety of the licensed Tdap vaccines. Continued monitoring of clinically significant AEs that are temporally associated with Tdap vaccination and further assessment of such events using controlled observational studies may provide additional information about the safety of these vaccines.
Patient was witnessed on the ground following his vaccination.  He has a loss of consciousness for about 30 seconds. we arrived to find the patient pale diaphoretic  with abrasions on his left side of his face and his eye glasses broken.   he was placed on the back board and taken to observation area two.  He is currently alert and oriented and by 3.  BP 133/90, HR 85, Resp 20, oxygen sat 100 on room air.  once in the observation area patient removed from the backboard.  he is sitting up on the bed and calling his significant other.  He was given apple juice and crackers.  he states he his feeling better.  The medical team at this time is encouraging the patient to be seen in the emergency department due to the the unwitnessed fall from seating position and the fact that he had a positive loss of consciousness.  Pt is not wanting to go to the ED due to the fact that he has bad insurance and currently unemployed.  12:50 Bp 138/86 HR 87 Resp18 Oxygen sat 100: on room air patient is feeling better however we are concerned about his LOC and wanting him to be evaluated. His partner arrived  BP 133/87 pulse oxygen 100 HR 76.    Once he was here he convinced pt to go to the ED.  EMS was called and arrived to take patient to the ED at 1343
Headache  NECK STIFFNESS; SWOLLEN ,RED, ITCHY ARM; TIRED; NAUSEA; SORE ACHY LEGS Narrative:  LASTED 3 DAYS  Other Relevant History: